MedPath

Investigating the Effect of Ursodeoxycholic acid and Phototherapy against Phototherapy alone in Reducing the Plasma Level of Bilirubin in Infants

Phase 3
Recruiting
Conditions
Hyperbilirubinemia.
Other disorders of bilirubin metabolism
E80.6
Registration Number
IRCT20231220060483N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

1. GA> 37 W
No Congenital abnormality
No Asphyxia
No congenital heart disease
No need for oxygen
Birth weight more than 2500
The age of the baby is between 2 and 14 days
No sepsis symptoms

Exclusion Criteria

Lack of parental consent
A baby admitted to the NICU
Initial serum bilirubin less than 15 g/d

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.